Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/1997
03/18/1997US5612319 Postexposure prevention of HIV infection or seroconversion
03/18/1997US5612316 Treatment of resistance to transplantation, fungal infections, and autoimmune diseases
03/18/1997US5612215 Stromelysin targeted ribozymes
03/13/1997WO1997009340A1 Compositions and methods for the synthesis of organophosphorus derivatives
03/13/1997WO1997009337A1 Metallocene-phosphoramidite conjugates, process for their preparation and their use
03/13/1997WO1997009052A1 Therapeutic azide compounds
03/13/1997CA2233460A1 Compositions and methods for the synthesis of organophosphorus derivatives
03/13/1997CA2231442A1 Therapeutic azide compounds
03/12/1997CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides
03/11/1997US5610292 Process for producing 2,2'-o-cyclonucleosides nucleosides, and analogs thereof
03/11/1997US5610289 Backbone modified oligonucleotide analogues
03/06/1997WO1997008182A1 Process for the preparation of imidazolyl macrolide immunosuppressants
03/06/1997CA2229718A1 Process for the preparation of imidazolyl macrolide immunosuppressants
03/05/1997EP0760375A1 Antitumor indolopyprolocarbazole derivative
03/05/1997EP0760008A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis
03/05/1997EP0759927A1 Pteridine nucleotide analogs as fluorescent dna probes
03/05/1997EP0759926A1 Process for producing arabino-nucleosides
03/05/1997EP0759925A1 Adenosine derivatives
03/05/1997EP0759784A1 Covalent microparticle-drug conjugates for biological targeting
03/05/1997EP0674647B1 Analytical technique for oligonucleotide analogs
03/05/1997EP0643069B1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
03/04/1997US5608063 Method, system and reagents for DNA sequencing
03/04/1997US5608049 Preparation of d4T from 5-methyluridine
03/04/1997US5608048 Polymorphic forms of 2',3'-didehydro-3'-deoxythymidine useful in the treatment of aids
03/04/1997US5608047 Cyclic ADP-ribose and analogs
03/04/1997US5608046 Conjugated 4'-desmethyl nucleoside analog compounds
03/04/1997US5608043 Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose compounds
03/04/1997US5607925 Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides
03/04/1997US5607923 Oligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purity
03/04/1997US5607922 1,5-anhydrohexitol nucleoside analogues
03/01/1997CA2184564A1 Chromatographic method and its use for separation of azadirachtin
02/1997
02/27/1997WO1997007125A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
02/27/1997WO1997003082A3 Pyrimidine nucleoside derivatives
02/27/1997CA2223814A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
02/26/1997EP0758897A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
02/26/1997CN1143966A L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus
02/25/1997US5606049 Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis
02/25/1997US5606048 Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
02/25/1997US5606038 Amphiphilic polyene macrolide antibiotic compounds
02/20/1997WO1997006179A1 Process for producing azido nucleoside derivatives
02/20/1997WO1997006178A1 Pyrimidine nucleosides
02/19/1997EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
02/18/1997US5604294 Macrocyclic immunomodulators
02/18/1997US5604234 Substituted thiol macrolactam immunomodulators
02/18/1997US5604182 Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses
02/13/1997WO1997005195A1 Method of detecting lung disease
02/13/1997WO1997005155A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use
02/13/1997WO1997005154A1 Improved therapeutic agents
02/13/1997WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
02/13/1997CA2226892A1 Method of detecting lung disease
02/13/1997CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
02/12/1997EP0604552B1 Method of synthesizing diverse collections of oligomers
02/12/1997EP0589933B1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
02/11/1997US5602246 Acylation, halogenation, amination, selective deacylation, sugar conversion, sulfonylation, nucleophilic displacement, and complete deacylation
02/11/1997US5602245 One vessel stereoselective glycosylation of purines and pyrimidines
02/11/1997US5602244 Dinucleoside precursors in oligonucleotide synthesis; useful as antisense inhibitors of translation
02/11/1997US5602240 Backbone modified oligonucleotide analogs
02/11/1997US5602118 A 2-((2-substituted alkyl)fur-3-yl)-thio-),3-carboxy-2-carbopenem derivatives; effective against beta-lactam antibiotic-resistant bacteria
02/11/1997US5602012 Culturing a mutant strain of actinomadura roseorufa
02/06/1997WO1996013512A3 L-ribofuranosyl nucleosides
02/05/1997EP0757056A1 Method for preparing 1-beta-D-arabinofuranosylcytosine
02/04/1997US5599950 Sulfonation of ring c#7 using a sulfonic anhydride followed by reacting with a borohydride to desulfonate and hydroxylate
02/04/1997US5599927 Macrocyclic immunomodulators with novel cyclohexyl ring replacements
02/04/1997US5599922 Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties
02/04/1997US5599797 Oligonucleotides having phosphorothioate linkages of high chiral purity
02/04/1997US5599796 Treatment of urogenital cancer with boron neutron capture therapy
01/1997
01/30/1997WO1997003084A1 New inhibitors of platelet aggregation
01/30/1997WO1997003083A1 Pyrimidine nucleoside derivative
01/30/1997WO1997003082A2 Pyrimidine nucleoside derivatives
01/30/1997DE19529025A1 Neue 8-bromsubstituierte cyclische Nucleotidester, Verfahren zu ihrer Herstellung und ihre Verwendung New 8-bromo-substituted cyclic Nucleotidester, processes for their preparation and their use
01/30/1997CA2226758A1 New inhibitors of platelet aggregation
01/30/1997CA2226096A1 Pyrimidine nucleoside derivatives
01/29/1997EP0755458A1 Electrogenerated chemiluminescence labels for analysis and/or referencing
01/29/1997EP0707590B1 Dideoxyfructonucleotides and deoxyfructonucleotides as dna polymerase substrates
01/29/1997CN1141300A Process for prepn. of ivermectin
01/29/1997CN1033914C Method for extrating kudzu vine root extract
01/23/1997WO1997002279A1 Methods and compositions for modulation and inhibition of telomerase
01/22/1997EP0754700A2 Labelling and detection of nucleic acids
01/22/1997EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES
01/22/1997CN1141045A Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene) cytidine
01/22/1997CN1141044A Antiparasitic agents
01/21/1997US5596094 Process for preparing 2' -0- alkyl adenosine derivatives
01/21/1997US5596093 Halogenation of 2,3-o-cyclocitidine with n-bromosuccinimide in the presence of acid
01/21/1997US5596087 Process for the preparation of beta thymidine
01/21/1997US5596086 Dimers with phosphodiester linkages for hybridization to target rna or dna sequences
01/21/1997US5595877 Methods of producing nucleic acid ligands
01/21/1997CA2115045C Composition for curing proliferative skin diseases
01/21/1997CA2055590C Chemiluminescent double-triggered 1,2-dioxetanes
01/16/1997WO1997001645A1 Primer walking cycle sequencing
01/16/1997WO1997001344A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
01/16/1997CA2225682A1 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
01/16/1997CA2224396A1 Primer walking cycle sequencing
01/15/1997EP0753525A1 Cyclic nucleotide derivative
01/15/1997EP0753002A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
01/15/1997EP0642528B1 Phosphotriester-type biologically active compounds
01/15/1997EP0473708B1 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives
01/15/1997CN1140453A 3'-substd. nucleoside derivs.
01/14/1997US5594155 Anomeric fluororibosyl amines
01/14/1997US5594124 Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
01/14/1997US5594121 Enhanced triple-helix and double-helix formation with oligomers containing modified purines